Profile data is unavailable for this security.
About the company
Paragon 28, Inc. is a medical device company. The Company develops, distributes, and sells medical devices in the foot and ankle segment of the orthopedic implant marketplace. Its products and product families include plates and plating systems, screws, staples, and nails to address all foot and ankle procedures, including fracture fixation, forefoot, or hallux valgus, which includes bunion and hammertoe, ankle, flatfoot, or progressive collapsing foot deformity (PCDF), Charcot foot and Ortho biologics. It provides a comprehensive portfolio of solutions that includes surgical implants and disposables, as well as surgical instrumentation. The Company’s suite of surgical solutions comprises 75 product systems, including approximately 9,200 SKUs, which comprises of approximately 6,800 implants, 1,400 instruments and 1,000 disposable and other SKUs. Its products are available in a variety of sizes and configurations to suit the individual patient’s anatomical and surgical requirements.
- Revenue in USD (TTM)216.39m
- Net income in USD-47.84m
- Incorporated2021
- Employees430.00
- LocationParagon 28 Inc14445 Grasslands DriveENGLEWOOD 80112United StatesUSA
- Phone+1 (720) 912-1332
- Fax+1 (302) 655-5049
- Websitehttps://paragon28.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Varex Imaging Corp | 877.80m | 44.60m | 632.95m | 2.30k | 23.23 | 1.11 | 8.01 | 0.7211 | 0.6712 | 0.6712 | 16.65 | 14.01 | 0.7245 | 1.95 | 5.90 | 365,750.00 | 3.72 | 0.9913 | 4.32 | 1.18 | 32.37 | 31.70 | 5.14 | 1.36 | 2.37 | 2.85 | 0.4322 | -- | 3.96 | 2.93 | 59.08 | 18.88 | 0.2924 | -- |
Fulgent Genetics Inc | 289.21m | -167.83m | 642.86m | 1.18k | -- | 0.5612 | -- | 2.22 | -5.64 | -5.64 | 9.71 | 38.31 | 0.2207 | -- | 5.57 | 244,267.70 | -13.37 | 16.70 | -14.25 | 18.37 | 36.12 | 67.89 | -60.59 | 29.06 | -- | -- | 0.0048 | 0.00 | -53.27 | 68.41 | -217.03 | -- | 57.08 | -- |
Treace Medical Concepts Inc | 187.12m | -49.53m | 681.30m | 516.00 | -- | 4.92 | -- | 3.64 | -0.8154 | -0.8154 | 3.08 | 2.23 | 0.9107 | 1.45 | 5.56 | 362,631.80 | -24.10 | -- | -29.51 | -- | 81.20 | -- | -26.47 | -- | 3.76 | -- | 0.2776 | -- | 31.92 | -- | -15.68 | -- | -- | -- |
Atrion Corp | 169.33m | 19.41m | 730.29m | 712.00 | 37.65 | 3.01 | 21.16 | 4.31 | 11.02 | 11.02 | 96.13 | 138.01 | 0.6444 | 1.44 | 7.21 | 237,817.40 | 7.39 | 11.96 | 7.85 | 12.62 | 36.84 | 41.99 | 11.46 | 19.05 | 2.57 | 92.92 | 0.00 | 42.42 | -7.73 | 2.12 | -44.55 | -10.74 | 4.98 | 11.27 |
Orthopediatrics Corp | 148.73m | -20.97m | 780.90m | 247.00 | -- | 2.04 | -- | 5.25 | -0.9251 | -0.9251 | 6.56 | 16.13 | 0.3433 | 0.4073 | 5.01 | 602,153.90 | -4.84 | -5.40 | -5.28 | -5.93 | 74.80 | 75.09 | -14.10 | -15.92 | 2.90 | -- | 0.026 | -- | 21.62 | 20.91 | -1,767.25 | -- | 28.29 | -- |
Silk Road Medical Inc | 185.49m | -53.42m | 799.88m | 474.00 | -- | 5.43 | -- | 4.31 | -1.37 | -1.37 | 4.76 | 3.73 | 0.7247 | 2.08 | 7.87 | 391,322.80 | -20.87 | -29.02 | -22.75 | -32.98 | 73.31 | 72.91 | -28.80 | -46.84 | 9.62 | -- | 0.34 | -- | 27.77 | 38.66 | -1.33 | -- | -7.92 | -- |
Cytek Biosciences Inc | 193.01m | -12.15m | 816.46m | 676.00 | -- | 2.07 | -- | 4.23 | -0.0887 | -0.0887 | 1.43 | 3.01 | 0.3807 | 1.53 | 3.68 | 285,523.70 | -2.40 | -- | -2.67 | -- | 56.69 | -- | -6.29 | -- | 5.89 | -- | 0.0056 | -- | 17.67 | -- | -571.58 | -- | -- | -- |
BioLife Solutions Inc | 143.27m | -66.43m | 816.76m | 409.00 | -- | 2.41 | -- | 5.70 | -1.52 | -1.52 | 3.28 | 7.48 | 0.332 | 2.46 | 5.45 | 350,298.30 | -15.40 | -13.76 | -17.12 | -15.04 | 32.63 | 36.76 | -46.36 | -42.99 | 1.83 | -30.52 | 0.0733 | -- | -11.43 | 48.65 | 52.49 | -- | 86.35 | -- |
Artivion Inc | 354.00m | -30.57m | 872.99m | 1.50k | -- | 3.05 | -- | 2.47 | -0.7496 | -0.7496 | 8.68 | 6.86 | 0.4553 | 1.60 | 5.30 | 236,002.70 | -3.95 | -2.20 | -4.24 | -2.36 | 64.74 | 65.51 | -8.67 | -5.34 | 3.43 | 0.6809 | 0.5246 | -- | 12.82 | 6.14 | -60.09 | -- | 5.13 | -- |
Paragon 28 Inc | 216.39m | -47.84m | 873.00m | 430.00 | -- | 4.91 | -- | 4.03 | -0.5819 | -0.5819 | 2.64 | 2.15 | 0.7276 | 0.5484 | 5.77 | 503,230.20 | -16.09 | -- | -20.14 | -- | 79.85 | -- | -22.11 | -- | 2.30 | -7.22 | 0.3832 | -- | 19.30 | -- | 28.94 | -- | -- | -- |
Avanos Medical Inc | 673.30m | -9.90m | 909.30m | 3.77k | -- | 0.735 | 25.12 | 1.35 | -0.2092 | -1.32 | 14.43 | 26.77 | 0.387 | 1.66 | 4.73 | 178,546.80 | -0.5691 | -0.6527 | -0.6473 | -0.7338 | 56.39 | 54.45 | -1.47 | -1.60 | 1.38 | 4.27 | 0.1196 | -- | -1.58 | 0.6357 | -146.05 | -- | -18.37 | -- |
AtriCure Inc | 414.60m | -37.23m | 1.01bn | 1.20k | -- | 2.21 | -- | 2.44 | -0.8005 | -0.8005 | 8.92 | 9.43 | 0.7059 | 1.70 | 8.21 | 345,501.70 | -6.34 | -3.72 | -7.08 | -4.10 | 75.26 | 74.36 | -8.98 | -7.64 | 2.83 | -13.41 | 0.1194 | -- | 20.84 | 14.64 | 34.49 | -- | 46.56 | -- |
Perspective Therapeutics Inc | 8.17m | -25.10m | 1.06bn | 88.00 | -- | 5.14 | -- | 130.07 | -0.1012 | -0.1012 | 0.0351 | 0.352 | 0.0944 | 4.91 | 5.55 | 92,852.27 | -29.01 | -- | -31.19 | -- | 22.96 | -- | -307.18 | -- | 2.55 | -- | 0.0173 | -- | -- | -- | -- | -- | -- | -- |
MiMedx Group Inc | 321.48m | 55.80m | 1.09bn | 895.00 | 28.56 | 7.55 | 16.97 | 3.38 | 0.2581 | 0.2192 | 2.19 | 0.976 | 1.57 | 3.19 | 6.63 | 359,192.20 | 32.86 | -4.14 | 42.03 | -5.90 | 83.01 | 83.61 | 20.98 | -2.70 | 3.11 | 7.11 | 0.256 | -- | 20.03 | -2.19 | 310.29 | -- | -26.47 | -- |
Coretag Inc | 0.00 | -39.35k | 1.13bn | -- | -- | -- | -- | -- | -0.4372 | -0.4372 | 0.00 | -0.93 | 0.00 | -- | -- | -- | -78,700.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 10.95 | -- | -- | -- |
Holder | Shares | % Held |
---|---|---|
First Light Asset Management LLCas of 31 Dec 2023 | 3.82m | 4.61% |
Braidwell LPas of 31 Dec 2023 | 3.36m | 4.06% |
BlackRock Fund Advisorsas of 31 Dec 2023 | 3.16m | 3.82% |
The Vanguard Group, Inc.as of 31 Dec 2023 | 1.94m | 2.34% |
Bleichroeder LPas of 31 Dec 2023 | 1.76m | 2.13% |
Point72 Asset Management LPas of 31 Dec 2023 | 1.29m | 1.55% |
SSgA Funds Management, Inc.as of 31 Dec 2023 | 1.11m | 1.34% |
Janus Henderson Investors US LLCas of 31 Dec 2023 | 914.25k | 1.10% |
Geode Capital Management LLCas of 31 Dec 2023 | 865.73k | 1.05% |
SEB Investment Management ABas of 31 Dec 2023 | 839.69k | 1.01% |